Table 3.
|
BCACs |
BCAs with ci. |
BCAs without ci. |
|
---|---|---|---|---|
(n=8) | (n=11) | (n=10) | ||
Predominant pattern |
Solid |
5 (62.5%) |
4 (36.4%) |
3 (30.0%) |
Cribriform |
2 (25.0%) |
4 (36.4%) |
0 (0.0%) |
|
Trabecular |
0 (0.0%) |
3 (27.3%) |
6 (60.0%) |
|
Tubular |
1 (12.5%) |
0 (0.0%) |
1 (10.0%) |
|
Mitosis |
> 4/10HPFs |
1 (12.5%) |
2 (18.2%) |
0 (0.0%) |
Perineural invasion |
1 (12.5%) |
0 (0.0%) |
0 (0.0%) |
|
Lymphovascular invasion |
0 (0.0%) |
0 (0.0%) |
0 (0.0%) |
|
Presence of daughter mass |
3 (37.5%) |
1 (9.1%) |
0 (0.0%) |
|
Cystic change |
3 (37.5%) |
3 (27.3%) |
0 (0.0%) |
|
Squamous differentiation | 1 (12.5%) | 1 (9.1%) | 0 (0.0%) |
BCAC, basal cell adenocarcinoma; BCA, basal cell adenoma; ci., capsular invasion; HPF, high power field.